Get the Stockscreener App
71.43
2.60%
-1.91
Henry Schein Inc stock is traded at $71.43, with a volume of 1.50M.
It is down -2.60% in the last 24 hours and up +12.68% over the past month.
Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology. It generates the majority of its revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.
See More
Previous Close:
$73.34
Open:
$72.73
24h Volume:
1.50M
Relative Volume:
0.95
Market Cap:
$8.66B
Revenue:
$12.50B
Net Income/Loss:
$314.00M
P/E Ratio:
29.27
EPS:
2.44
Net Cash Flow:
$421.00M
1W Performance:
-0.65%
1M Performance:
+12.68%
6M Performance:
+1.93%
1Y Performance:
+7.35%
1-Day Range:
$71.33
$73.31
1-Week Range:
$71.33
$73.63
52-Week Range:
$60.56
$82.49
Henry Schein Inc Stock (HSIC) Company Profile
Name
Henry Schein Inc
Sector
Industry
Phone
(631) 843-5500
Address
135 DURYEA RD, MELVILLE, NY
Compare HSIC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HSIC
Henry Schein Inc
|
71.43 | 8.63B | 12.50B | 314.00M | 421.00M | 2.44 |
|
MCK
Mckesson Corporation
|
842.09 | 104.45B | 387.09B | 4.23B | 6.01B | 32.12 |
|
COR
Cencora Inc
|
361.94 | 70.85B | 321.33B | 1.57B | 3.21B | 7.9518 |
|
CAH
Cardinal Health Inc
|
205.37 | 48.96B | 234.31B | 1.61B | 4.45B | 6.6243 |
|
AHG
Akso Health Group Adr
|
1.41 | 807.33M | 2.22M | -5.63M | -1.68M | -0.24 |
Henry Schein Inc Stock (HSIC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-26-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Jul-25-25 | Downgrade | Stifel | Buy → Hold |
| Jul-14-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Feb-14-25 | Initiated | Wells Fargo | Equal Weight |
| Jan-06-25 | Upgrade | BofA Securities | Underperform → Buy |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Jul-22-24 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Dec-12-23 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-10-23 | Upgrade | Stifel | Hold → Buy |
| Aug-08-22 | Upgrade | UBS | Sell → Neutral |
| Jul-21-22 | Downgrade | Goldman | Buy → Neutral |
| Jun-14-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-13-22 | Resumed | Credit Suisse | Outperform |
| Jan-31-22 | Initiated | Morgan Stanley | Underweight |
| Jan-07-22 | Upgrade | Credit Suisse | Neutral → Outperform |
| Oct-01-21 | Resumed | Credit Suisse | Neutral |
| Feb-08-21 | Resumed | Piper Sandler | Overweight |
| Jan-04-21 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Nov-03-20 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| May-06-20 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Apr-07-20 | Upgrade | Goldman | Neutral → Buy |
| Apr-02-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jan-09-20 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jan-02-20 | Upgrade | Evercore ISI | Underperform → In-line |
| Aug-07-19 | Downgrade | William Blair | Outperform → Mkt Perform |
| May-30-19 | Initiated | Wolfe Research | Underperform |
| May-15-19 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-18-19 | Initiated | Guggenheim | Buy |
| Jan-17-19 | Initiated | UBS | Sell |
| Jan-03-19 | Downgrade | Evercore ISI | In-line → Underperform |
| Jan-02-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Nov-08-18 | Reiterated | Barrington Research | Outperform |
| Oct-25-18 | Downgrade | Edward Jones | Hold → Sell |
| Oct-19-18 | Resumed | Goldman | Neutral |
| Oct-04-18 | Reiterated | Robert W. Baird | Outperform |
| Aug-07-18 | Reiterated | Stifel | Hold |
| Apr-24-18 | Downgrade | Goldman | Buy → Neutral |
| Apr-04-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
View All
Henry Schein Inc Stock (HSIC) Latest News
Key metrics from Henry Schein Inc.’s quarterly dataMarket Activity Summary & Safe Investment Capital Preservation Plans - newser.com
Is Henry Schein Inc. stock dividend yield sustainableJuly 2025 Selloffs & Weekly High Return Stock Forecasts - newser.com
Analyzing drawdowns of Henry Schein Inc. with statistical tools2025 Market Sentiment & Free Community Supported Trade Ideas - newser.com
What recovery options are there for Henry Schein Inc.Market Movement Recap & Reliable Breakout Forecasts - newser.com
Chart based exit strategy for Henry Schein Inc.Weekly Trade Recap & Daily Chart Pattern Signals - newser.com
Henry Schein Inc. stock volume spike explainedQuarterly Portfolio Review & Technical Analysis for Trade Confirmation - newser.com
Tools to assess Henry Schein Inc.’s risk profileJuly 2025 Sentiment & Detailed Earnings Play Strategies - newser.com
What risks investors should watch in Henry Schein Inc. stockWeekly Stock Recap & Weekly Stock Performance Updates - newser.com
Henry Schein, Inc.'s (NASDAQ:HSIC) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue? - 富途牛牛
Applying sector rotation models to Henry Schein Inc.July 2025 Action & Community Consensus Stock Picks - newser.com
Is Henry Schein Inc. stock ready for breakoutMarket Growth Review & AI Driven Price Forecasts - newser.com
What moving averages say about Henry Schein Inc.2025 Institutional Moves & Free Weekly Chart Analysis and Trade Guides - newser.com
New Two-Volume Book UNJUST GAGGLE OF GAVELS Exposes Corruption in Oklahoma Medical Laboratory Industry - GlobeNewswire Inc.
Henry Schein to Participate in Upcoming Investor Conference in December - The Globe and Mail
Has Henry Schein Inc. found a price floorMarket Performance Summary & Consistent Profit Focused Trading Strategies - newser.com
Henry Schein at Stifel 2025 Healthcare Conference: Strategic Initiatives and Growth - Investing.com Nigeria
Transcript : Henry Schein, Inc. Presents at Stifel 2025 Healthcare Conference, Nov-12-2025 11 - MarketScreener
Will Henry Schein Inc. rebound enough to break evenQuarterly Earnings Report & Real-Time Volume Analysis - newser.com
The Bull Case For Henry Schein (HSIC) Could Change Following Launch of AI-Powered Impact Panel Integration - simplywall.st
Will earnings trigger a reversal in Henry Schein Inc.Weekly Trading Summary & Daily Growth Stock Investment Tips - newser.com
Henry Schein (HSIC) Receives a Hold from UBS - The Globe and Mail
Will Henry Schein Inc. stock attract more institutional investorsQuarterly Portfolio Review & Risk Controlled Daily Plans - newser.com
Can Henry Schein Inc. recover in the next quarter2025 Performance Recap & Step-by-Step Swing Trade Plans - newser.com
What candlestick patterns are forming on Henry Schein Inc.2025 Winners & Losers & High Accuracy Investment Entry Signals - newser.com
Henry Schein Inc. Stock Rises Monday, Still Underperforms Market - 富途牛牛
Nuance Investments Dumps $38 Million in Henry Schein (NASDAQ: HSIC) Shares: Should Investors Sell Too? - The Motley Fool
Will Henry Schein Inc. stock split again soonWeekly Stock Analysis & Short-Term Trading Alerts - newser.com
Henry Schein signals over $200M operating income improvement opportunity as BOLD+1 and KKR partnership advance - MSN
Henry Schein Inc. (HSIC) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Here's Why Henry Schein (HSIC) is a Strong Momentum Stock - sharewise.com
Henry Schein (HSIC): Evaluating Valuation After Strong Q3 Results and Upgraded Guidance - simplywall.st
Using flow based indicators on Henry Schein Inc.Weekly Stock Analysis & Weekly Setup with High ROI Potential - newser.com
J.P. Morgan Sticks to Its Buy Rating for Henry Schein (HSIC) - The Globe and Mail
Jim Cramer on Henry Schein: “I Think It’s a Good Stock” - Insider Monkey
Henry Schein Inc Stock (HSIC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Henry Schein Inc Stock (HSIC) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| LASKAWY PHILIP A | Director |
Mar 19 '25 |
Sale |
71.04 |
2,604 |
184,999 |
24,805 |
| Connett Bradford C | CEO, NA Distribution Group |
Mar 19 '25 |
Sale |
71.15 |
4,036 |
287,161 |
62,688 |
4.08%
0.43%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):